EAHP represents over 30,000 hospital pharmacists across 37 member countries. EAHP represents and develops the hospital pharmacy profession within Europe in order to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professional
The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
The EAHP staff supports the Board in executing EAHP’s mission. The Staff assists in financial management, events organisations, policy activities and all EAHP projects. The EAHP staff works closely with EAHP’s members and ensures the effective communication all relevant stakeholders.
The first member countries were Belgium, Britain, Denmark, France, the Federal Republic, Germany, Italy and The Netherlands in 1972. EAHP has now 36 EAHP members and 2 Associate Members. EAHP is open to countries members of the Council of Europe and since 2022 to organisations representing the interests of hospital pharmacists from outside the Council of Europe (Associate Membership)
EAHP’s structure is also composed by different standing committes: EAHP Scientific Committee, EAHP Education Executive Committee and the EAHP CTF Steering Committee.
At EAHP, we are committed to transparency in our governance, ethical standards, and funding practices. This section provides open access to our foundational documents, including the EAHP Statutes, Code of Conduct, and Funding Sources. By sharing these resources, we aim to uphold accountability and foster trust with our members, partners, and the public.
Keep up with all EAHP’s events and webinars. Contact the team at info@eahp.eu should you have any questions about upcoming events or activities.
Here you can find all upcoming events organised by EAHP and by all its members and associate members. Do not hesitate to contact the events team at events@eahp.eu should you have any questions about the organisation of these events.
Hospital pharmacists conduct a critical role in the care of patients in hospitals. Learn more about what they do here and in all the pages under Hospital Pharmacy practice and Policy.
Self-Assessment
SILCC
Closed SIGs
EAHP brings together experts from many areas of hospital pharmacy practice providing and highlighting good local sustainable practices as that can be up-scaled and shared with other countries. The EAHP Working Group on Sustainability has the aim of reducing the environmental burden of the hospital pharmacy services.
The European Association of Hospital Pharmacists (EAHP), and its 36 member country platforms are creating a Common Training Framework for the hospital pharmacy education in Europe. The goal of this project is to allow the free movement of hospital pharmacists within the European Union.
The European Association of Hospital Pharmacists (EAHP) and the European Society of Clinical Pharmacy (ESCP) have collaboratively developed the Oath to Society. The Oath to Society is all encompassing and acts as a contract for excellence in providing compassionate patient care, working as part of the healthcare team and advancing the pharmacy profession, and showcasing how clinical and hospital pharmacists work every day
A day created to highlight the importance and to celebrate the work done by hospital pharmacies. This day celebrates all hospital pharmacy teams.
The Early Career Network aims to empower early-career pharmacists by sharing opportunities, insights, and success stories from across 25 member countries.
Together, we’re building a stronger, more connected hospital pharmacy community: one story, one country, one pharmacist at a time.
Catch up with EAHP’s press releases
Find all EAHP relevant publication like the EAHP Surveys, annual reports and the history books.
The European Journal of Hospital Pharmacy (EJHP) is the only official journal of the European Association of Hospital Pharmacists (EAHP) and is committed to advancing the science, practice and profession of hospital pharmacy. As the premier communication platform for hospital pharmacists worldwide, EJHP is a major source for continuing education as well as updates on advances in the practice and standard of pharmaceutical care for patients.
When EAHP and Hospital pharmacists appear in the news.
EAHP publishes a monthly EU monitor with updates about the latest EAHP initiatives and information relevant for the hospital pharmacy profession.
The Sponsor Channel is designed to maximise visibility and engagement, allowing sponsors to connect with the hospital pharmacy community and partners in a dynamic and interactive environment. From product demonstrations to networking sessions, the Sponsor Channel offers a range of opportunities for sponsors to showcase their offerings and generate leads in the new EAHP Website.
Patient Safety and Quality Assurance
Álvaro Caballero Romero, Enrique Galindo Sacristán, Fernando Malpica Chica , Enriqueta González González, Ana María Manzano Bonilla, Marcos Camacho Romera
Medication errors (ME) are often identified in transitions of patients at admission to and discharge from the hospital. Medication reconciliation at discharge is an effective process to decrease the morbidity, mortality and healthcare expenses.
A protocol for a medication reconcialiation project was designed by hospital and primary health care pharmacists.
The protocol has the following steps. To identify all the patients from the hospital at discharge daily. To select the polimedicated (5 or more prescribed medicament) and elderly (over 65 years old) patients. To review the discharge report in the clinical history patient in order to compare whether doctor prescriptions of medicaments (medicine, dose, posology, duration) correspond to the prescriptions included in the report at discharge. To identify discrepancies between both the discharge report and doctor prescriptions of medicaments. The discrepancies were clasified in justified and unjustified. The unjustified discrepancies were categorised as omissions, unnecesary addition, wrong medications, wrong drug frequency/dose, duplicities, pharmacological interacctions and inappropiated medicine regarding to the current clinical practice guidelines. The discrepancies are classified as high and low priority. Finally, both types of discrepancias are reported by sending emails to the specific physicians for each patient along the primary health care system. Some specific cases are discussed on phone calls by doctors and the pharmacists in order to achieve the best clinical goal for the patient.
The project was evaluated from June 2016 to May 2017. Total of discharges: 2788. Included patients: 863. Patients with discrepancies: 309 (35%). Detected discrepancies: 470. Rate discrepancies/patient: 1.52. Omissions: 122 of 470. (25.96%). Unnecesary addition: 60 of 470 (12.76%). Wrong medicine: 3 (0.63%). Wrong frequency/dose: 167 (35.53%). Duplicities: 92 (19.57%). Pharmacological interactions: 13 (2.65%). Inappropiated medicine: 13 (2.77%). Reported emails: 309/309 (100%).
Polimedicated and over 65 years old patients play an extremely important role in the current health care systems. The ME are frequent and may be particullary severe in this type of patients. To develope a protocol for medication reconciliation at discharge in order to identify potencial prescriptions problems is an oppotunity for the multidisciplinar care team to improve the patient care and decrease the expenses associated to primary health care.
Introductory Statements and Governance
Lars-Åke Söderlund, Marie Olsson Nerfeldt , Birgitta Elfsson
Clinical Pharmacy Services
Medication reconciliation at admission was implemented in our hospital in 2011 and since then we could hardly meet the expectations of clinicians (completion of a Best Possible Medication History (BPMH) for 70% of patients in less than 24 hours). We also observed that the high patient volume decreased the quality of our BPMH completion process.
We developed a strategy and an organisational thinking to remove human and technology barriers in performing medication reconciliation (MR). We designed a program to improve the overall quality of MR and increase the added value of MR for clinicians, nurses and pharmacists.
Our approach included four steps:
(1) “customer approach”; by conducting semi-structured interviews with students, clinicians and nurses to get their feedback, needs, expectations about medication reconciliation,
(2) literature review with Pubmed® and Embase®and benchmarking of other similar practices in France and Canada
(3) set a task force including pharmacists and students to define a strategy and metrics
(4) design solutions and assess them.
First, we defined and chose to target “High risk” admission inpatients only. Second, a training program based on two e-learning modules was implemented to develop skills of pharmacy students and residents. This program explores the “why” of conducting MR based on real life examples. It also defines the “what” (what is MR) and the “how” (i.e the different steps to run a MR and how to appropriately interact with the patient).
At each student rotation, the efficacy of the training program will be evaluated by comparing the concordance of BPMHs performed separately by a student and a pharmacist. A survey will be conducted to evaluate the level of learners’ satisfaction.
